Cell Source

Cell Therapy Treatments Based on Immune Tolerance

Startup

Cell Source is a Bnei Brak-based startup in the Health Tech & Life Sciences sector, established in 2011. Cell Therapy Treatments Based on Immune Tolerance. The company has raised a total of $21.54M across 1 funding round, currently at the Public stage. The company has 11-50 employees. Core technologies: Biologicals, Cells.

With $21.54M in total funding, Cell Source is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.

$21.54M
Raised
1
Rounds
2
Team
2011
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue EngineeringBiologicalsCells
At a Glance
In the News

2 articles covered by sources including finance.yahoo.com.

finance.yahoo.com · Dec 19, 2024
Cell Source Presents Potential Breakthrough in the Development of Off-the-Shelf CAR-T Cell Therapy at American Society of Hematology Annual Meeting
Read article ↗
Frequently Asked Questions
What does Cell Source do?

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company's patented Veto Cell technology enables safe and selective tuning of immune responses. Veto Cells are white blood cells taken from either the patient or a healthy third-party donor. They are then processed using a proprietary mix of off-the-shelf, FDA-approved cytokines that change their characteristics and activate their inherent attacker-blocking capability. Once reintroduced into the body intravenously, they can perform a number of important functions. Potential applications range from facilitating bone marrow and organ transplantation to effectively treating blood cancers such as lymphoma and nonmalignant congenital diseases such as sickle cell anemia.

How much funding has Cell Source raised?

Cell Source has raised $21.54M in total funding across 1 rounds. The company is currently at the Public stage.

What sector is Cell Source in?

Cell Source operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Biomaterials & Tissue Engineering, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.

Where is Cell Source located?

Cell Source is based in Kinneret St 5, Bnei Brak, Israel, Center District. The company also has offices abroad.

View Full Profile Classic View Website ↗